International professional education covering cannabinoid science, clinical practice, evidence, and regulatory frameworks — for healthcare professionals, researchers and policy leaders worldwide.
The Institute provides education only. It does not provide medical advice or supply medicinal cannabis products.
About the Institute
An independent international academy for cannabinoid medicine.
The Institute for Cannabinoid Therapy is an independent international educational organisation bringing together clinicians, scientists and regulatory experts from multiple jurisdictions. Together, they build a rigorous, evidence-based curriculum that advances the safe and responsible practice of cannabinoid therapeutics.
International
Educators drawn from across the continents.
Academically led
Curriculum set by our academic leadership, not by any product interest.
Evidence-based
Grounded in current science and clinical trial data.
Practitioner-first
Built for the clinical and regulatory realities of practice.
Why Study Cannabinoid Medicine
A rapidly evolving field that demands rigour.
01
Rapid scientific development
The evidence base for cannabinoid therapeutics is expanding at unprecedented pace.
02
Increasing clinical interest
Patients and colleagues are asking informed questions in every specialty.
03
Changing international regulation
Regulatory landscapes are shifting across most major jurisdictions.
04
Evidence-based education
Rigorous appraisal is essential to separate signal from noise.
05
Patient safety first
Understanding benefits, limitations, contraindications and interactions.
Learning Pathway
A structured route from foundations to focused clinical depth.
The Institute's flagship programme: twelve modules spanning cannabinoid science, safety, clinical applications and prescribing, taught by international clinicians and researchers.
Individual modules on regulation, jurisdiction by jurisdiction.
Short, purchasable modules comparing prescribing frameworks, product access and practitioner responsibilities in a single jurisdiction — released progressively as each is written and reviewed.
Jurisdiction modules are released progressively. Register your interest to be notified as each becomes available.
These reviews are educational only and do not constitute legal advice. Regulations change frequently. Practitioners remain responsible for understanding and complying with local laws applicable to their jurisdiction and scope of practice.
Educators
Led by Professor Kylie O'Brien, Director of Education.
Our teaching is directed by Professor Kylie O'Brien — academic, clinical researcher and author of three Springer titles. Further educators are being confirmed and added as each joins the teaching team.
Multi-continental Published authors Active researchers Dedicated educators
Every module is shaped by academic leadership and clinical experience — spanning ECS biology, clinical pharmacology, pain, mental health, women's health and regulatory science.
Begin
Ready to advance your practice in cannabinoid medicine?
Enrol in the Foundation Course (USD $500) or purchase individual modules (USD $100 each), including focused modules on regulation in your jurisdiction.